Latest News

Saverio Gravina (FPG) and Marie Théry (PSI) showcased the project's ambitions and its work on scandium-44 to the IHI community. On 20–21 October 2026, Thera4Care took part in the IHI Forum 2026 in Brussels, with two poster presentations from Saverio Gravina, Fondazione Policlinico Universitario Agostino Gemelli IRCCS (FPG), and Marie Théry, Paul Scherrer Institute (PSI). About the IHI Forum 2026 Organised by the Innovative Health Initiative (IHI), this year's Forum took the t

The consortium took part in the Annual Congress of the European Association of Nuclear Medicine through oral presentations, project meetings and various forms of representation. From 17 to 21 October 2026, Thera4Care partners came together at EANM26, the Annual Congress of the European Association of Nuclear Medicine (EANM), at the Austria Center Vienna. It was the first time the project attended the congress as an active consortium, with an oral presentation, three keynotes

New study in EJNMMI Radiopharmacy and Chemistry addresses long-standing production challenges for a promising PET imaging radionuclide Researchers working within the Thera4Care consortium have published an optimised method for producing, purifying, and radiolabelling scandium-44, an emerging radionuclide for positron emission tomography (PET) imaging. The paper, Unlocking the potential of scandium-44: reproducible production and radiolabelling methods towards clinical use in

Preclinical study published in EJNMMI Research supports work on next-generation radioligand therapy for sarcoma Researchers at the Paul Scherrer Institute (PSI) and ETH Zurich, working within the Thera4Care consortium, have published a new preclinical study comparing two candidate radionuclides for targeted cancer therapy: lutetium-177, already used in the clinic, and terbium-161, an emerging alternative. The paper, Preclinical characterisation of FAP-targeting radioconjugate

Thera4Care partners, University Hospital Essen (UK-Essen) and GE HealthCare have reached an important milestone with the installation of the GE HealthCare StarGuide SPECT/CT system, a state-of-the-art imaging platform designed to advance molecular imaging and support the future of personalised cancer care. Installed in the hospital’s newly inaugurated Nuclear Medicine Center, the StarGuide system will enhance both clinical practice and research and represents an important mil

The 22nd European Symposium on Radiopharmacy and Radiochemistry (ESRR) took place on April 16-19 in Bergen, Norway. Thera4Care was represented by Maria Rosaria Ruggiero from Gemelli Medipass Ergea with a poster titled "Public survey on radiotheranostic landscape by Thera4Care IHI project". More information about the conference can be found here. The next version will be taking place on April 20-23, 2028 in Dijon, France.

Thera4Care's Annual Meeting 2026 took place in Brussels, Belgium, from 5 to 6 May 2026 and hosted by Institut Jules Bordet. Around 60 participants representing consortium partners met together in Brussels to discuss progress of the last 2 years and align on plans for the next year. The first day started with updates from work packages 1 (Project management), 2 (Regulatory) and 9 (Education, Training, Guidelines and Dissemination). The afternoon dove into breakout sessions, wh

The European Molecular Imaging Meeting (EMIM) took place in Ljubljana, Slovenia, from 24 to 27 March 2026. Members from UK-Essen attended the event and presented results from Thera4Care in their two posters titled: Investigating the Effects of Tumor Microenvironment-Targeted Radioligand Therapy on Cancer-Associated Fibroblasts LRRC15-Targeted Radioligand Therapy for the TME-targeted Treatment of Pancreatic Ductal Adenocarcinoma More information about the conference can be fou

The 12th International Conference on Isotopes (12ICI) took place in Florence, Italy, from 15 to 19 February 2026, bringing together scientists, professionals, and stakeholders to share knowledge on the production, applications, and regulation of isotopes across scientific, medical, industrial, and environmental fields. Themes addressed in the conference included: 1) Isotope production and separation; 2) Radiopharmaceuticals and nuclear medicine; 3) Environmental and geologica